Screener
Maze Therapeutics MAZE Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Maze Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The source filing: Maze Therapeutics’s 10-Q, filed August 11, 2026.
- Filed
- Aug 11, 2026, 4:48 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-344903
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Cash and cash equivalents | $202,643 | $189,247 |
| Marketable securities, current | 208,444 | 152,670 |
| Prepaid expenses and other current assets | 9,336 | 7,800 |
| Total current assets | 420,423 | 349,717 |
| Property and equipment, net | 4,391 | 5,044 |
| Restricted cash | 1,088 | 1,088 |
| Marketable securities, non-current | 83,821 | 18,114 |
| Operating lease right-of-use asset | 18,442 | 20,116 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Maze Therapeutics's total current assets?
- Maze Therapeutics (MAZE) reported total current assets of $420.42M in Q2 2026.
- How has Maze Therapeutics's total current assets changed year-over-year?
- Maze Therapeutics's total current assets increased by 55.1% year-over-year, from $271.15M to $420.42M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.
Ask your AI about Maze Therapeutics's total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude